BIOMAT Database Logo BIOMAT Database Logo

[Acute electrophysiologic effects of propafenone in patients with accessory pathways]. 1987

R Sanjuán Máñez, and R García Civera, and S Morell Cabedo, and E González Hernández, and J Muñoz Gil, and R Ruiz Granell, and J Sanchís Fores, and J Llavador Sanchís

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011405 Propafenone An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity. Apo-Propafenone,Arythmol,Baxarytmon,Cuxafenon,Fenoprain,Jutanorm,Nistaken,Norfenon,Pintoform,Prolecofen,Propafenon AL,Propafenon Hexal,Propafenon Minden,Propafenone Hydrochloride,Propafenone Hydrochloride, (R)-Isomer,Propafenone Hydrochloride, (S)-Isomer,Propafenone, (+-)-Isomer,Propafenone, (R)-Isomer,Propafenone, (S)-Isomer,Propamerck,Rythmol,Rytmo-Puren,Rytmogenat,Rytmonorm,SA-79,Hydrochloride, Propafenone,SA 79,SA79
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013610 Tachycardia Abnormally rapid heartbeat, usually with a HEART RATE above 100 beats per minute for adults. Tachycardia accompanied by disturbance in the cardiac depolarization (cardiac arrhythmia) is called tachyarrhythmia. Tachyarrhythmia,Tachyarrhythmias,Tachycardias

Related Publications

R Sanjuán Máñez, and R García Civera, and S Morell Cabedo, and E González Hernández, and J Muñoz Gil, and R Ruiz Granell, and J Sanchís Fores, and J Llavador Sanchís
Electrophysiologic effects of propafenone.
December 1984, American heart journal,
R Sanjuán Máñez, and R García Civera, and S Morell Cabedo, and E González Hernández, and J Muñoz Gil, and R Ruiz Granell, and J Sanchís Fores, and J Llavador Sanchís
[Electrophysiologic effects of propafenone in patients with sinus node dysfunction].
April 1984, Giornale italiano di cardiologia,
R Sanjuán Máñez, and R García Civera, and S Morell Cabedo, and E González Hernández, and J Muñoz Gil, and R Ruiz Granell, and J Sanchís Fores, and J Llavador Sanchís
[Electrophysiologic effects of intravenous propafenone].
June 1989, Zhonghua xin xue guan bing za zhi,
R Sanjuán Máñez, and R García Civera, and S Morell Cabedo, and E González Hernández, and J Muñoz Gil, and R Ruiz Granell, and J Sanchís Fores, and J Llavador Sanchís
Gender differences of electrophysiologic characteristics in patients with accessory atrioventricular pathways.
April 2011, Heart rhythm,
R Sanjuán Máñez, and R García Civera, and S Morell Cabedo, and E González Hernández, and J Muñoz Gil, and R Ruiz Granell, and J Sanchís Fores, and J Llavador Sanchís
Ablation of Accessory Pathways with Uncommon Electrophysiologic Properties.
December 2020, Cardiac electrophysiology clinics,
R Sanjuán Máñez, and R García Civera, and S Morell Cabedo, and E González Hernández, and J Muñoz Gil, and R Ruiz Granell, and J Sanchís Fores, and J Llavador Sanchís
Efficacy of ajmaline and propafenone in patients with accessory pathways: a prospective randomized study.
October 1994, Journal of cardiovascular pharmacology,
R Sanjuán Máñez, and R García Civera, and S Morell Cabedo, and E González Hernández, and J Muñoz Gil, and R Ruiz Granell, and J Sanchís Fores, and J Llavador Sanchís
Electrophysiologic and hemodynamic effects of intravenous propafenone in patients with recurrent ventricular tachycardia.
May 1984, Journal of the American College of Cardiology,
R Sanjuán Máñez, and R García Civera, and S Morell Cabedo, and E González Hernández, and J Muñoz Gil, and R Ruiz Granell, and J Sanchís Fores, and J Llavador Sanchís
Antiarrhythmic and electrophysiologic effects of oral propafenone.
November 1984, The American journal of cardiology,
R Sanjuán Máñez, and R García Civera, and S Morell Cabedo, and E González Hernández, and J Muñoz Gil, and R Ruiz Granell, and J Sanchís Fores, and J Llavador Sanchís
[Electrophysiologic characteristics of multiple atrioventricular accessory pathways in patients with pre-excitation syndrome].
June 1991, Zhonghua xin xue guan bing za zhi,
R Sanjuán Máñez, and R García Civera, and S Morell Cabedo, and E González Hernández, and J Muñoz Gil, and R Ruiz Granell, and J Sanchís Fores, and J Llavador Sanchís
Electrophysiologic effects and clinical efficacy of oral propafenone therapy in patients with ventricular tachycardia.
June 1985, Journal of the American College of Cardiology,
Copied contents to your clipboard!